
The Medical Brief
Evidence-based medicine, made clear. Each week, The Medical Brief breaks down important studies, emerging treatments, diseases, and the science shaping modern healthcare. Clear context, careful explanations, and no sensationalism. For educational purposes only, not medical advice. Brought to you by Jellypod.
Episodes (26)

Beyond GLP-1: The Next Wave of Obesity Drugs

Aspirin After Joint Replacement: The EPCAT III Shift

Oxygen After Cardiac Arrest: What the LOGICAL Trial Found

Gene Silencing vs Stabilization in ATTR Cardiomyopathy

Are Beta-Blockers Still Needed After a Heart Attack?

Teclistamab in Early Myeloma Relapse: Promise and Peril

PCSK9 Inhibitors in Primary Prevention

CHAMPION-AF: Can a Heart Device Replace Blood Thinners?

Valproate, Paternal Risk, and the Confounding Mirage

Why Delaying STEMI Reperfusion Fell Flat

Magnetic Shunt Trial Solves a 60-Year NPH Mystery

When Cross-Protection Fails: The GoGoVax Reality Check

YEARS in Cancer Patients: What the Hydra Trial Really Means

Once-Weekly HIV Therapy: A New Era for Adherence

Finerenone’s New Role in HFpEF and HFmrEF

Baxdrostat and the New Frontier in Resistant Hypertension

CREST 2 and the Asymptomatic Carotid Dilemma

Iptacopan in IgA Nephropathy: Slowing Kidney Failure

Fixed-Duration Therapy Challenges Continuous CLL Treatment

EARLY TAVR and the Asymptomatic Paradox

Do Shock Patients Need an Arterial Line Right Away?

Bicarbonate in Shock: Why Fixing the pH Isn’t Enough

C-TRACT Trial: Stenting Gains, Bleeding Costs

Finerenone in Non-Diabetic CKD: FIND-CKD Explained

KarXT and the End of Dopamine-Only Schizophrenia Treatment
